General Information

Company Name CellGenTech, Inc.
Founded October 20, 2003
Head Office Chiba-dai Inohana Innovation Plaza #101
1-8-15, Inohana, Chuo-ku, Chiba-city, Chiba 260-0856 Japan mapMap
Facilities for
Research & Production
Chiba-dai Inohana Innovation Plaza open link in new window
CellGenTech Tokyo Suidobashi-South Bld.5F, 2-7-9 Nishikanda, Chiyoda-ku, Tokyo 101-0065 Japan mapMap
Website http://www.cellgentech.com/
Management Masayuki Aso, President & CEO
Masami Tanio - Senior Director, Clinical Development
Takahiro Shimada - Senior Director, Managerial Planning
Tetsuya Mishima, External Board Member
Yoshitaka Tanaka, External Board Member
Hiromu Hara, Auditor
Akira Shiga, Auditor
Kiyokazu Nemoto, Auditor
Logo logo

Management Members

Masayuki Aso - President & CEO
Joined Eisai Co., Ltd. in 1981, and was in charge of product planning for pharmaceutical business. Was involved in postmarketing surveilance and clinical developments.
Joined AnGes MG, Inc. in 2001, and was engaged in debvelopments of nucleic acid drugs and gene therapy in charge of clinical developments and business planning.
Founded CellGenTech, Inc. in 2003, and assumed President & CEO.
Masami Tanio - Senior Director, Clinical Development
Joined Green Cross Corp. (Mitsubishi Pharma Corporation) in 1978, and was engaged in drug developments from research to clinical developments.
Joined Mebix, Inc. in 2003, and was involved in planning promotion in the area of commissioned clinical drug research.
Joined CellGenTech, Inc. as a senior director in 2006.
Takahiro Shimada - Senior Director, Managerial Planning
Joined the securities companies including Daiwa Securities Co. Ltd. 1992 to 2000 and a consulting company with the initial public offering 2001.
Joined CellGenTech, Inc. as the managerial planning manager and 2016 and became a Director
Tetsuya Mishima - External Board Member
Joined Asahi Glass Co., Ltd. in 1987
Joined the Investment Banking Division of Bank of America in 2000.
Took part in the establishment of Watervein Partners in 2002, and became a Venture Partners of the Company (He is still in tenure of this position at present.)
Joined CellGenTech, Inc. and became a Director
Yoshitaka Tanaka - External Board Member
Hiromu Hara Ph.D. - Auditor
Joined Yamanouchi Pharmaceutical Co., Ltd. in 1984, and was engaged in new drug discovery, Corporate Planning and Intellectual Property.
Joined CellGenTech, Inc. in 2018.
Akira Shiga - Auditor
Joined Eisai Co., Ltd. in 1966, and was engaged in Clinical Development/Quality Control and Drug Business Planning with responsibility for R&D.
Joined CellGenTech, Inc. in 2004, and was appointed Director.
Kiyokazu Nemoto - Auditor
Joined Mitsui Knowledge Industry Co., Ltd. in 1975, and was engaged in system developments for financial field and bioscience field.
Worked as facilitator at Incubation institutes for Venture Business at Chiba University. Joined CellGenTech, Inc. in 2018.